Publication Name	World Journal of Clinical Oncology
Manuscript ID	11200
Country	India

Received	2014-05-08 20:58
Peer-Review Started	2014-05-09 18:51
First Decision by Editorial Office Director
Return for Revision	2014-07-11 14:30
Revised	2014-12-19 00:55
Publication Fee Transferred
Second Decision by Editor	2015-09-21 17:14
Second Decision by Editor-in-Chief	2015-09-23 18:23
Final Decision by Editorial Office Director	2015-10-08 17:45
Articles in Press	2015-10-08 17:45
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-26 15:02
Publish the Manuscript Online	2015-12-09 18:37

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Biomarkers in triple negative breast cancer: A review
Manuscript Source	Unsolicited Manuscript
All Author List	Budhi S Yadav, Priyanka Chanana and Swaty Jhamb
Funding Agency and Grant Number
Corresponding Author	Dr. Budhi S Yadav, Associate Professor, Department of Radiotherapy, PGIMER, Sector 12, Chandigarh 160012, India. drbudhi@gmail.com
Key Words	Cyclin; p53; Vascular endothelial growth factor; Epidermal growth factor receptor; Triple negative breast cancer
Core Tip	Triple negative breast cancer (TNBC) are type of breast cancer which lack of estrogen receptors, progesterone receptors and human epidermal growth factor receptor. It is a complex disease subtype with many subclasses. There are many biomarkers in TNBC used for its sub-classification. Clinically-practical assay/biomarkers that can reliably identify TNBC are necessary. Biomarkers may be useful as prognostic or predictive indicators as well as suggest possible targets for novel therapies.
Publish Date	2015-12-09 18:37
Citation	Yadav BS, Chanana P, Jhamb S. Biomarkers in triple negative breast cancer: A review. World J Clin Oncol 2015; 6(6): 252-263
URL	http://www.wjgnet.com/2218-4333/full/v6/i6/252.htm
DOI	http://dx.doi.org/10.5306/wjco.v6.i6.252

Full Article (PDF)	WJCO-6-252.pdf
Full Article (Word)	WJCO-6-252.doc
Manuscript File	11200-Review.doc
Answering Reviewers	11200-Answering reviewers.pdf
Audio Core Tip	11200-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	11200-Conflict-of-interest statement.pdf
Copyright License Agreement	11200-Copyright assignment.pdf
Peer-review Report	11200-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	11200-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	11200-Scientific misconduct check.pdf
Scientific Editor Work List	11200-Scientific editor work list.pdf